Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

66.92 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 66.92
Bid (Size) 66.80 (1)
Ask (Size) 67.00 (1)
Prev. Close 66.92
Today's Range 66.92 - 66.92
52wk Range 54.73 - 67.96
Shares Outstanding 2,232,843,755
Dividend Yield 2.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors
Exelixis, Inc. (Nasdaq: EXEL) today announced a clinical trial collaboration and supply agreement with Bristol-Myers Squibb Company (NYSE: BMY) for STELLAR-002, a new phase 1b trial evaluating XL092 in... 
From Business Wire News Releases
Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today
Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and ... 
Tags Benzinga Trading Ideas ELAN
From Benzinga

Performance

YTD
+9.03%
+9.03%
1 Month
+2.23%
+2.23%
3 Month
+7.62%
+7.62%
6 Month
+7.35%
+7.35%
1 Year
+17.28%
+17.28%

More News

Read More
Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassemia
From Business Wire News Releases
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
Tags AMGN WKME CNVY
From Benzinga
Bristol Myers Squibb and GRYT Health Evolve Virtual Patient Advocacy Experience
From Business Wire News Releases
Johnson & Johnson Building Case With New Patient Survival Data For Darzalex In Multiple Myeloma
Tags Biotech News Briefs
From Benzinga
Bristol Myers Squibb a Top Socially Responsible Dividend Stock With 2.9% Yield (BMY)
Tags ETFs
From ETF Channel
Bristol Myers Squibb to Report Results for Second Quarter 2021 on July 28, 2021
From Business Wire News Releases
Is bluebird bio's Surge a Bellwether for Gene Editing Stocks?
Tags BMY Market News TMO
From Motley Fool
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 TRANSFORM Trial Evaluating Breyanzi (lisocabtagene maraleucel) Versus Chemotherapy Followed by Stem Cell Transplant in Second-line
From Business Wire News Releases
Here's Where to Invest $1,000 Right Now
Tags Market News FB BMY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.